189 related articles for article (PubMed ID: 21447608)
1. Individual variability in the detoxification of carcinogenic arylhydroxylamines in human breast.
Rhoads K; Sacco JC; Drescher N; Wong A; Trepanier LA
Toxicol Sci; 2011 Jun; 121(2):245-56. PubMed ID: 21447608
[TBL] [Abstract][Full Text] [Related]
2. Reductive detoxification of arylhydroxylamine carcinogens by human NADH cytochrome b5 reductase and cytochrome b5.
Kurian JR; Chin NA; Longlais BJ; Hayes KL; Trepanier LA
Chem Res Toxicol; 2006 Oct; 19(10):1366-73. PubMed ID: 17040106
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome b5 and NADH cytochrome b5 reductase: genotype-phenotype correlations for hydroxylamine reduction.
Sacco JC; Trepanier LA
Pharmacogenet Genomics; 2010 Jan; 20(1):26-37. PubMed ID: 19997042
[TBL] [Abstract][Full Text] [Related]
4. Polymorphisms in the carcinogen detoxification genes CYB5A and CYB5R3 and breast cancer risk in African American women.
Blanke KL; Sacco JC; Millikan RC; Olshan AF; Luo J; Trepanier LA
Cancer Causes Control; 2014 Nov; 25(11):1513-21. PubMed ID: 25225034
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of polymorphisms in the sulfonamide detoxification genes NAT2, CYB5A, and CYB5R3 in patients with sulfonamide hypersensitivity.
Sacco JC; Abouraya M; Motsinger-Reif A; Yale SH; McCarty CA; Trepanier LA
Pharmacogenet Genomics; 2012 Oct; 22(10):733-40. PubMed ID: 22850190
[TBL] [Abstract][Full Text] [Related]
6. Crystal structures of the naturally fused CS and cytochrome b
Benson DR; Lovell S; Mehzabeen N; Galeva N; Cooper A; Gao P; Battaile KP; Zhu H
Acta Crystallogr D Struct Biol; 2019 Jul; 75(Pt 7):628-638. PubMed ID: 31282472
[TBL] [Abstract][Full Text] [Related]
7. Discovery and characterization of a cytochrome b5 variant in humans with impaired hydroxylamine reduction capacity.
Kurian JR; Longlais BJ; Trepanier LA
Pharmacogenet Genomics; 2007 Aug; 17(8):597-603. PubMed ID: 17622936
[TBL] [Abstract][Full Text] [Related]
8. NADH cytochrome b5 reductase and cytochrome b5 catalyze the microsomal reduction of xenobiotic hydroxylamines and amidoximes in humans.
Kurian JR; Bajad SU; Miller JL; Chin NA; Trepanier LA
J Pharmacol Exp Ther; 2004 Dec; 311(3):1171-8. PubMed ID: 15302896
[TBL] [Abstract][Full Text] [Related]
9. P450 redox enzymes in the white rot fungus Phanerochaete chrysosporium: gene transcription, heterologous expression, and activity analysis on the purified proteins.
Subramanian V; Doddapaneni H; Syed K; Yadav JS
Curr Microbiol; 2010 Oct; 61(4):306-14. PubMed ID: 20221604
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of polymorphisms in the sulfonamide detoxification genes CYB5A and CYB5R3 in dogs with sulfonamide hypersensitivity.
Funk-Keenan J; Sacco J; Wong YY; Rasmussen S; Motsinger-Reif A; Trepanier LA
J Vet Intern Med; 2012; 26(5):1126-33. PubMed ID: 22816446
[TBL] [Abstract][Full Text] [Related]
11. Identification of a cytochrome b-type NAD(P)H oxidoreductase ubiquitously expressed in human cells.
Zhu H; Qiu H; Yoon HW; Huang S; Bunn HF
Proc Natl Acad Sci U S A; 1999 Dec; 96(26):14742-7. PubMed ID: 10611283
[TBL] [Abstract][Full Text] [Related]
12. Familial Congenital Methemoglobinemia in Pomeranian Dogs Caused by a Missense Variant in the NADH-Cytochrome B5 Reductase Gene.
Shino H; Otsuka-Yamasaki Y; Sato T; Ooi K; Inanami O; Sato R; Yamasaki M
J Vet Intern Med; 2018 Jan; 32(1):165-171. PubMed ID: 29356095
[TBL] [Abstract][Full Text] [Related]
13. Combined ascorbate and glutathione deficiency leads to decreased cytochrome b5 expression and impaired reduction of sulfamethoxazole hydroxylamine.
Bhusari S; Abouraya M; Padilla ML; Pinkerton ME; Drescher NJ; Sacco JC; Trepanier LA
Arch Toxicol; 2010 Aug; 84(8):597-607. PubMed ID: 20221587
[TBL] [Abstract][Full Text] [Related]
14. Role of carboxyl residues surrounding heme of human cytochrome b5 in the electrostatic interaction with NADH-cytochrome b5 reductase.
Kawano M; Shirabe K; Nagai T; Takeshita M
Biochem Biophys Res Commun; 1998 Apr; 245(3):666-9. PubMed ID: 9588172
[TBL] [Abstract][Full Text] [Related]
15. Reduction of sulfamethoxazole and dapsone hydroxylamines by a microsomal enzyme system purified from pig liver and pig and human liver microsomes.
Clement B; Behrens D; Amschler J; Matschke K; Wolf S; Havemeyer A
Life Sci; 2005 May; 77(2):205-19. PubMed ID: 15862605
[TBL] [Abstract][Full Text] [Related]
16. Transient kinetics of intracomplex electron transfer in the human cytochrome b5 reductase-cytochrome b5 system: NAD+ modulates protein-protein binding and electron transfer.
Meyer TE; Shirabe K; Yubisui T; Takeshita M; Bes MT; Cusanovich MA; Tollin G
Arch Biochem Biophys; 1995 Apr; 318(2):457-64. PubMed ID: 7733677
[TBL] [Abstract][Full Text] [Related]
17. A single-nucleotide polymorphism in the canine cytochrome b
Reinhart JM; Ekena J; Cioffi AC; Trepanier LA
J Vet Pharmacol Ther; 2018 Jun; 41(3):402-408. PubMed ID: 29336038
[TBL] [Abstract][Full Text] [Related]
18. Effect of mutations in porcine CYB5A and CYP17A1 on the metabolism of pregnenolone.
Squires EJ; Gray MA; Lou Y
J Steroid Biochem Mol Biol; 2019 Dec; 195():105469. PubMed ID: 31509771
[TBL] [Abstract][Full Text] [Related]
19. The involvement of mitochondrial amidoxime reducing components 1 and 2 and mitochondrial cytochrome b5 in N-reductive metabolism in human cells.
Plitzko B; Ott G; Reichmann D; Henderson CJ; Wolf CR; Mendel R; Bittner F; Clement B; Havemeyer A
J Biol Chem; 2013 Jul; 288(28):20228-37. PubMed ID: 23703616
[TBL] [Abstract][Full Text] [Related]
20. CYB5A polymorphism increases androgens and reduces risk of rheumatoid arthritis in women.
Stark K; Straub RH; Rovenský J; Blažičková S; Eiselt G; Schmidt M
Arthritis Res Ther; 2015 Mar; 17(1):56. PubMed ID: 25890314
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
